<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Inbaraj SD</style></author><author><style face="normal" font="default" size="100%">Muniappan M</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Correlation between the in-vitro and in-vivo Antihyperglycemic Effect of Ocimum Sanctum, Trigonella Foenum Graecum and Curcuma Longa</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Curcuma longa</style></keyword><keyword><style  face="normal" font="default" size="100%">GLP-1</style></keyword><keyword><style  face="normal" font="default" size="100%">Glucagon</style></keyword><keyword><style  face="normal" font="default" size="100%">Insulin</style></keyword><keyword><style  face="normal" font="default" size="100%">Ocimum sanctum</style></keyword><keyword><style  face="normal" font="default" size="100%">Trigonella foenum graecum</style></keyword><keyword><style  face="normal" font="default" size="100%">Type 2 diabetes mellitus</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">369-376</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;This study is carried out to investigate the correlation between the &lt;em&gt;in-vitro&lt;/em&gt; and &lt;em&gt;in-vivo&lt;/em&gt; studies which demonstrates the antihyperglycemic effect of &lt;em&gt;Trigonella foenum graecum, Ocimum sanctum &lt;/em&gt;and &lt;em&gt;Curcuma longa &lt;/em&gt;extracts. Methanolic seed extract of &lt;em&gt;Trigonella foenum graecum&lt;/em&gt;, methanolic leaf extract of &lt;em&gt;Ocimum sanctum&lt;/em&gt;, ethyl acetate rhizomes extract of &lt;em&gt;Curcumina longa &lt;/em&gt;are prepared and supplied by Sami labs, Bangalore, India on request.&lt;em&gt; in-vitro &lt;/em&gt;studies such as alpha glucosidase inhibitory and DPP-IV inhibitory activity were done for all the three extracts as per previous studies. After Institutional animal ethical committee clearance male albino rats (155–215 g) were divided into 5 groups. Each group consists of randomly assigned 6 albino rats. The placebo (Normal saline) control group, Standard (Vildagliptin) group and 3 above mentioned extract groups. Oral glucose tolerance test (OGTT) was done. Blood samples were collected for blood sugar estimation at -30 (before extract),0, 15, 45 minutes and blood sugar levels were done by enzymatic assay.&lt;strong&gt; Results: &lt;/strong&gt;The maximum alpha-glucosidase inhibitory activity at 100 μg/ml by&lt;em&gt; Trigonella foenum graecum&lt;/em&gt; extract was 68% with IC&lt;sub&gt;50&lt;/sub&gt; value of 57.25, &lt;em&gt;Ocimum sanctum&lt;/em&gt; leaf extract was 65% with IC&lt;sub&gt;50 &lt;/sub&gt;value of 59.55, &lt;em&gt;Curcuma longa&lt;/em&gt; was 72% with IC&lt;sub&gt;50 &lt;/sub&gt;value of 56.79 when compared to the Acarbose (STD) of 94% with IC&lt;sub&gt;50&lt;/sub&gt; values of 42.78. The maximum % of DPP IV inhibition at 320 μg/ml of &lt;em&gt;Trigonella foenum graecum &lt;/em&gt;extract was 77.84% with IC50 value of 52.26, &lt;em&gt;Ocimum sanctum&lt;/em&gt; extract was 86.98% with IC&lt;sub&gt;50&lt;/sub&gt; value of 46.08 and &lt;em&gt;Curcuma longa&lt;/em&gt; was 76.47% with IC&lt;sub&gt;50&lt;/sub&gt; value of 55.06 when compared to the Vildagliptin (STD) was 80.15% with IC&lt;sub&gt;50&lt;/sub&gt; value of 22.98. The OGTT results of &lt;em&gt;Ocimum sanctum &lt;/em&gt;(200 mg/kg) shows reduction in blood glucose (&lt;em&gt;p&lt;/em&gt;=&amp;lt;0.05) at 15 minutes and significant reduction (&lt;em&gt;p&lt;/em&gt;=&amp;lt;0.001) at 45 minutes and &lt;em&gt;Trigonella foenum &lt;/em&gt;graecum (2 gm/kg) showed significant reduction in blood glucose (&lt;em&gt;p&lt;/em&gt;=&amp;lt;0.001) at 15 minutes when compared to control. Further clinical studies are necessary to establish the therapeutic potential of these extracts in the treatment of type 2 diabetes mellitus. &lt;strong&gt;Conclusion:&lt;/strong&gt;&lt;em&gt; Ocimum sanctum&lt;/em&gt; leaf extract, &lt;em&gt;Trigonella foenum &lt;/em&gt;graecum seed extract shows significant alpha-glucosidase and DPPIV inhibitory activity which correlates with the antihyperglycemic effects by in-vivo oral glucose tolerance test. Further clinical studies are necessary to establish the therapeutic potential of these extracts in the treatment of type 2 diabetes mellitus.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">369</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Inbaraj SD*, Muniappan M* &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Department of Pharmacology, Sree Balaji Medical College and Hospital, Bharath Institute of Higher Education and Research [BIHER]. No. 7 Works Road, Chromepet, Chennai-600044, INDIA.&lt;/p&gt;
</style></auth-address></record></records></xml>